Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).

Six dairy herds in Nevada have tested positive for a newer strain of the H5N1 bird flu virus that’s been associated with ...

American Heart Association News Heart disease is once again the leading cause of death in the U.S., according to a new statistical report from the American Heart Association. Cardiovascular diseases, ...

The Centers for Disease Control and Prevention and other federal agencies have altered or removed hundreds of pages of ...

The 2025 respiratory season has reached Greater Cincinnati and is already having an impact on schools and hospitals across ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of breast cancer, extends its sincere ...

Two thirds of nurses experiencing mental health issues are not receiving treatment. Some states are pushing for legislation to change that.

The most common cardiovascular killer in maternal medicine is also among the most misdiagnosed. Peripartum cardiomyopathy ...

The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...

To address the gap, the Minister inaugurated the National Nuclear Medicine Technical Working Group (NMTWG) on Tuesday to ...

Research is increasingly demonstrating that the way you take care of yourself today may have a big effect on your health later in life. For example, studies have linked midlife fitness with reduced ...